{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:19:09Z","timestamp":1793395149149,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:00:00Z","timestamp":1555113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Czech Ministery of Interior Affairs","award":["VI20172020056"],"award-info":[{"award-number":["VI20172020056"]}]},{"name":"Czech Ministery of Education, Youth and Sports","award":["LO1611"],"award-info":[{"award-number":["LO1611"]}]},{"name":"Charles University Prague","award":["PROGRES Q35"],"award-info":[{"award-number":["PROGRES Q35"]}],"id":[{"id":"https:\/\/ror.org\/024d6js02","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00213-019-05236-w","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T11:04:10Z","timestamp":1555153450000},"page":"2653-2666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms"],"prefix":"10.1007","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7903-1325","authenticated-orcid":false,"given":"M. V.","family":"Uthaug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lancelotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"van Oorsouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P. C.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"\u0160ul\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jurok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mary\u0161ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kucha\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"P\u00e1len\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Riba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"key":"5236_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0269881114544776","volume":"29","author":"CG Abdallah","year":"2015","unstructured":"Abdallah CG, Salas R, Jackowski A, Baldwin P, Sato JR, Mathew SJ (2015) Hippocampal volume and the rapid antidepressant effect of ketamine. J Psychopharmacol 29:591\u2013595","journal-title":"J Psychopharmacol"},{"key":"5236_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1073191105283504","volume":"13","author":"RA Baer","year":"2006","unstructured":"Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L (2006) Using self-report assessment methods to explore facets of mindfulness. Assessment 13:27\u201345","journal-title":"Assessment"},{"key":"5236_CR3","unstructured":"Barsuglia J, Davis A, Palmer R (2017) Characterization of mystical experiences occasioned by 5-MeO-DMT-containing toad bufotoxin and comparison with prior psilocybin studies. Psychedelic Sci 23"},{"key":"5236_CR4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3389\/fpsyg.2018.02459","volume":"9","author":"JP Barsuglia","year":"2018","unstructured":"Barsuglia JP, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant RM, Griffiths RR (2018) Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. Front Psychol 9:2459","journal-title":"Front Psychol"},{"key":"5236_CR5","first-page":"3","volume":"201209","author":"J Beuningen","year":"2012","unstructured":"Beuningen J (2012) The satisfaction with life scale examining construct validity. Stat Neth 201209:3\u201323","journal-title":"Stat Neth"},{"key":"5236_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PCR, Strassman RJ (2015) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29:289\u2013299","journal-title":"J Psychopharmacol"},{"key":"5236_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","volume":"228","author":"BJ Catlow","year":"2013","unstructured":"Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J (2013) Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Exp Brain Res 228:481\u2013491","journal-title":"Exp Brain Res"},{"key":"5236_CR8","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/jps.2600561202","volume":"56","author":"K Chen","year":"1967","unstructured":"Chen K, Kova\u0159\u00edkov\u00e1 A (1967) Pharmacology and toxicology of toad venom. J Pharm Sci 56:1535\u20131541","journal-title":"J Pharm Sci"},{"key":"5236_CR9","doi-asserted-by":"publisher","first-page":"12863","DOI":"10.1038\/s41598-017-12779-5","volume":"7","author":"V Dakic","year":"2017","unstructured":"Dakic V, Minardi Nascimento J, Costa Sartore R, Maciel RM, de Araujo DB, Ribeiro S, Martins-de-Souza D, Rehen SK (2017) Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Sci Rep 7:12863","journal-title":"Sci Rep"},{"issue":"7","key":"5236_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/0269881118769063","volume":"32","author":"AK Davis","year":"2018","unstructured":"Davis AK, Barsuglia JP, Lancelotta R, Grant RM, Renn E (2018) The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: benefits, consequences, patterns of use, subjective effects, and reasons for consumption. J Psychopharmacol 32(7):779\u2013792","journal-title":"J Psychopharmacol"},{"key":"5236_CR11","doi-asserted-by":"publisher","unstructured":"Davis AK, So S, Lancelotta R, Barsuglia JP, Griffiths RR (2019) 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic setting is associated with unintended improvements in depression and anxiety. Am J Drug Alcohol Abuse. \n                    https:\/\/doi.org\/10.1080\/00952990.2018.1545024","DOI":"10.1080\/00952990.2018.1545024"},{"key":"5236_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1023\/A:1016014818163","volume":"24","author":"P Daza","year":"2002","unstructured":"Daza P, Novy DM, Stanley MA, Averill P (2002) The depression anxiety stress scale-21: Spanish translation and validation with a Hispanic sample. J Psychopathol Behav Assess 24:195\u2013205","journal-title":"J Psychopathol Behav Assess"},{"key":"5236_CR13","unstructured":"De Lima Os\u00f3rio F, De Macedo LRH, De Sousa JPM, Pinto JP, Quevedo J, de Souza Crippa JA, Hallak JEC (2011) The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies. Ethnopharmacol Ayahuasca 75\u201386"},{"key":"5236_CR14","unstructured":"Derogatis LR (2001) Brief symptom inventory 18. Johns Hopkins University, Johns Hopkins University"},{"key":"5236_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","volume":"49","author":"E Diener","year":"1985","unstructured":"Diener E, Emmons RA, Larsen RJ, Griffin S (1985) The satisfaction with life scale. J Pers Assess 49:71\u201375","journal-title":"J Pers Assess"},{"key":"5236_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979351","volume":"31","author":"A Dittrich","year":"1998","unstructured":"Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31:80\u201384","journal-title":"Pharmacopsychiatry"},{"key":"5236_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68\u201372","journal-title":"Science"},{"key":"5236_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0006-2952(67)90147-5","volume":"16","author":"V Erspamer","year":"1967","unstructured":"Erspamer V, Vitali T, Roseghini M, Cei JM (1967) 5-Methoxy-and 5-hydroxyindoles in the skin of Bufo alvarius. Biochem Pharmacol 16:1149\u20131164","journal-title":"Biochem Pharmacol"},{"key":"5236_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.286.5439.487","volume":"286","author":"WE Evans","year":"1999","unstructured":"Evans WE, Relling MV (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487\u2013491","journal-title":"Science"},{"key":"5236_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12874-016-0283-3","volume":"17","author":"GH Franke","year":"2017","unstructured":"Franke GH, Jaeger S, Glaesmer H, Barkmann C, Petrowski K, Braehler E (2017) Psychometric analysis of the brief symptom inventory 18 (BSI-18) in a representative German sample. BMC Med Res Methodol 17:14","journal-title":"BMC Med Res Methodol"},{"key":"5236_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1874473708666150107121331","volume":"7","author":"A Garcia-Romeu","year":"2014","unstructured":"Garcia-Romeu A, Griffiths RR, Johnson MW (2014) Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev 7:157\u2013164","journal-title":"Curr Drug Abuse Rev"},{"key":"5236_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30:1181\u20131197","journal-title":"J Psychopharmacol"},{"key":"5236_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1037\/pas0000263","volume":"28","author":"J Gu","year":"2016","unstructured":"Gu J, Strauss C, Crane C, Barnhofer T, Karl A, Cavanagh K, Kuyken W (2016) Examining the factor structure of the 39-item and 15-item versions of the Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive therapy for people with recurrent depression. Psychol Assess 28:791\u2013802","journal-title":"Psychol Assess"},{"key":"5236_CR24","first-page":"215","volume-title":"Pharmacogenetics and toxicological consequences of human drug oxidation and reduction","author":"H Hadidi","year":"1999","unstructured":"Hadidi H, G\u00fczey C, Idle J (1999) Pharmacogenetics and toxicological consequences of human drug oxidation and reduction. General and Applied Toxicology. Basingstoke, Macmillan Reference, pp 215\u2013250"},{"key":"5236_CR25","unstructured":"Hammerson G, Georgina S-B (2004) Incilius alvarius. The IUCN Red List of Threatened Species 2004. IUCN"},{"key":"5236_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","volume":"44","author":"JD Henry","year":"2005","unstructured":"Henry JD, Crawford JR (2005) The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44:227\u2013239","journal-title":"Br J Clin Psychol"},{"key":"5236_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mehy.2017.01.013","volume":"100","author":"RD Idell","year":"2017","unstructured":"Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S (2017) The fibrinolytic system: a new target for treatment of depression with psychedelics. Med Hypotheses 100:46\u201353","journal-title":"Med Hypotheses"},{"key":"5236_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"MW Johnson","year":"2008","unstructured":"Johnson MW, Richards WA, Griffiths RR (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22:603\u2013620","journal-title":"J Psychopharmacol"},{"key":"5236_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","volume":"189","author":"K Krebs-Thomson","year":"2006","unstructured":"Krebs-Thomson K, Ruiz EM, Masten V, Buell M, Geyer MA (2006) The roles of 5-HT 1A and 5-HT 2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology 189:319\u2013329","journal-title":"Psychopharmacology"},{"key":"5236_CR30","doi-asserted-by":"crossref","unstructured":"Ku\u010dera D, Havigerov\u00e1 J, Haviger J, Cvr\u010dek V, Urb\u00e1nek T, Jel\u00ednek T, Luke\u0161 D, Komrskov\u00e1 Z (2018) V\u00fdzkum CPACT: Komputa\u010dn\u00ed psycholingvistick\u00e1 anal\u00fdza \u010desk\u00e9ho textu (CPACT research: computational psycholinguistic analysis of Czech Text. \u010cesk\u00e9 Bud\u011bjovice, PF JU. (in press)","DOI":"10.5593\/sgemsocial2017\/32\/S11.010"},{"key":"5236_CR31","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00213-016-4377-8","volume":"233","author":"KP Kuypers","year":"2016","unstructured":"Kuypers KP, Riba J, de la Fuente RM, Barker S, Theunissen EL, Ramaekers JG (2016) Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233:3395\u20133403","journal-title":"Psychopharmacology"},{"key":"5236_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.paid.2015.09.040","volume":"93","author":"IZ Lebudaa","year":"2015","unstructured":"Lebudaa IZ, Zabelina D, Karwowski M (2015) Mind full of ideas: a meta-analysis of the mindfulness\u2013creativity link. Personal Individ Differ 93:22\u201326","journal-title":"Personal Individ Differ"},{"key":"5236_CR33","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41467-017-01709-8","volume":"8","author":"Z Ma","year":"2017","unstructured":"Ma Z, Zang T, Birnbaum SG, Wang Z, Johnson JE, Zhang CL, Parada LF (2017) TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response. Nat Commun 8:1668","journal-title":"Nat Commun"},{"key":"5236_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnhum.2016.00269","volume":"10","author":"MM Nour","year":"2016","unstructured":"Nour MM, Evans L, Nutt D, Carhart-Harris RL (2016) Ego-dissolution and psychedelics: validation of the Ego-dissolution inventory (EDI). Front Hum Neurosci 10:269","journal-title":"Front Hum Neurosci"},{"key":"5236_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/02791072.2001.10399925","volume":"33","author":"J Ott","year":"2001","unstructured":"Ott J (2001) Pharmepena-psychonautics: human intranasal, sublingual and oral pharmacology of 5-methoxy-N, N-dimethyl-tryptamine. J Psychoactive Drugs 33:403\u2013407","journal-title":"J Psychoactive Drugs"},{"key":"5236_CR36","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1021\/jo01091a032","volume":"24","author":"IJZ Pachter","year":"1959","unstructured":"Pachter IJZ, Ribeiro DE, Ribeiro O (1959) Indole alkaloids of acer saccharinum (the silver maple), Dictyoloma incanescens, Piptadenia colubrina, and Mimosa hostilis. J Org Chem 24:1285\u20131287","journal-title":"J Org Chem"},{"key":"5236_CR37","unstructured":"Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Os\u00f3rio FL, Sanches R, dos Santos RG (2018) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 1\u20139"},{"key":"5236_CR38","unstructured":"PsychedelicsToday (2018) Psychedelic today\u2019s - 5-MeO-DMT course (unpublished). Psychedelic Today \n                    https:\/\/psychedelicstoday.teachable.com\/\n                    \n                  . Accessed 12 December 2018"},{"key":"5236_CR39","doi-asserted-by":"publisher","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","volume":"5","author":"TS Ray","year":"2010","unstructured":"Ray TS (2010) Psychedelics and the human receptorome. PLoS One 5:e9019","journal-title":"PLoS One"},{"key":"5236_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fphar.2017.00974","volume":"8","author":"L Roseman","year":"2017","unstructured":"Roseman L, Nutt DJ, Carhart-Harris RL (2017) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 8:974","journal-title":"Front Pharmacol"},{"key":"5236_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30:1165\u20131180","journal-title":"J Psychopharmacol"},{"key":"5236_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","volume":"20","author":"F Sampedro","year":"2017","unstructured":"Sampedro F, de la Fuente RM, Valle M, Roberto N, Dominguez-Clave E, Elices M, Luna LE, Crippa JAS, Hallak JEC, de Araujo DB, Friedlander P, Barker SA, Alvarez E, Soler J, Pascual JC, Feilding A, Riba J (2017) Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol 20:698\u2013711","journal-title":"Int J Neuropsychopharmacol"},{"key":"5236_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","volume":"36","author":"RF Sanches","year":"2016","unstructured":"Sanches RF, de Lima OF, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE (2016) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 36:77\u201381","journal-title":"J Clin Psychopharmacol"},{"key":"5236_CR44","unstructured":"Sandoval GR (2006) The god molecule: 5-MeO-DMT and the spiritual path to the divine Light, Divine Arts"},{"key":"5236_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2174\/138920010794233495","volume":"11","author":"HW Shen","year":"2010","unstructured":"Shen HW, Jiang XL, Winter JC, Yu AM (2010) Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab 11:659\u2013666","journal-title":"Curr Drug Metab"},{"key":"5236_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00213-015-4162-0","volume":"233","author":"J Soler","year":"2016","unstructured":"Soler J, Elices M, Franquesa A, Barker S, Friedlander P, Feilding A, Pascual JC, Riba J (2016) Exploring the therapeutic potential of ayahuasca: acute intake increases mindfulness-related capacities. Psychopharmacology 233:823\u2013829","journal-title":"Psychopharmacology"},{"key":"5236_CR47","doi-asserted-by":"publisher","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","volume":"5","author":"E Studerus","year":"2010","unstructured":"Studerus E, Gamma A, Vollenweider FX (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 5:e12412","journal-title":"PLoS One"},{"key":"5236_CR48","doi-asserted-by":"publisher","first-page":"e106533","DOI":"10.1371\/journal.pone.0106533","volume":"9","author":"A Szabo","year":"2014","unstructured":"Szabo A, Kovacs A, Frecska E, Rajnavolgyi E (2014) Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PLoS One 9:e106533","journal-title":"PLoS One"},{"key":"5236_CR49","doi-asserted-by":"crossref","unstructured":"Uthaug M, van Oorsouw K, Kuypers K, van Boxtel M, Broers N, Mason N, Toennes S, Riba J, Ramaekers J (2018) Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology 1\u201311","DOI":"10.1007\/s00213-018-4988-3"},{"key":"5236_CR50","doi-asserted-by":"publisher","first-page":"E82","DOI":"10.1017\/sjp.2013.82","volume":"16","author":"C Vazquez","year":"2013","unstructured":"Vazquez C, Duque A, Hervas G (2013) Satisfaction with life scale in a representative sample of Spanish adults: validation and normative data. Span J Psychol 16:E82","journal-title":"Span J Psychol"},{"key":"5236_CR51","unstructured":"Wardenaar KJ, Wanders RBK, Jeronimus BF, al e (2017) The psychometric properties of an internet-administered version of the Depression Anxiety and Stress Scales (DASS) in a Sample of Dutch Adults. J Psychopathol Behav Assess 1\u201316"},{"key":"5236_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-8741(94)90051-5","volume":"41","author":"AT Weil","year":"1994","unstructured":"Weil AT, Davis W (1994) Bufo alvarius: a potent hallucinogen of animal origin. J Ethnopharmacol 41:1\u20138","journal-title":"J Ethnopharmacol"},{"key":"5236_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00008571-200303000-00007","volume":"13","author":"A-M Yu","year":"2003","unstructured":"Yu A-M, Idle JR, Byrd LG, Krausz KW, K\u00fcpfer A, Gonzalez FJ (2003) Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenet Genomics 13:173\u2013181","journal-title":"Pharmacogenet Genomics"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05236-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05236-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05236-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:30:13Z","timestamp":1586633413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05236-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,13]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5236"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05236-w","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,13]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Review Committee for Psychology and Neuroscience (ERCPN), from Maastricht University, Maastricht, The Netherlands. Participation was voluntary and no incentives, monetary, or otherwise, were offered in exchange for participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests. None of the authors of this paper were directly involved in any way with the organization of the sessions where vapor from dried toad secretion was inhaled.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}